Sunho Biologics,Inc. (HK:2898) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Sunho Biologics, Inc. has issued a supplemental announcement to their previous disclosures regarding a transaction related to fund subscriptions, providing the Chinese names of the general partners involved from Prudent Wealth, Vanguard, and North Rock. The company emphasizes that all other details previously announced remain valid, and this update should be read in conjunction with those announcements for complete understanding.
For further insights into HK:2898 stock, check out TipRanks’ Stock Analysis page.